The Pfizer and Moderna COVID vaccines currently available for use in the United States are being heralded as the best way to keep the pandemic in check, but the virus will continue to spread until collective immunity is achieved, meaning that thousands of others they will get sick – or even die. Fortunately, new research suggests that a common drug may be effective in preventing the disease from progressing or becoming fatal. Read on to find out what the new research says, and if you’re concerned about being exposed to the virus, if you have these 4 new symptoms, you probably have COVID, study found.
According to a February 2021 study published in The BMJ, patients who receive anticoagulants one day after admission to a hospital with COVID have a greater chance of survival than those who do not. Among a sample of 4,297 patients with COVID with an average age of 68 years, those who received anticoagulants within 24 hours after being admitted to the hospital with COVID had their relative risk of dying from COVID reduced by 34 percent compared to individuals who did not receive anticoagulants.
Blood clots are a common – and often fatal – occurrence in patients with COVID; according to a research review published in the January 2021 volume of the journal Medical Hypotheses, approximately one third of patients with severe COVID have blood clotting or elevated levels of D-dimer, a protein found in the bloodstream after a clot has separated.
However, anticoagulants are not the only drugs that have proven effective in combating the most serious side effects of COVID; Read on to find out what other medications and supplements may be the key to surviving the virus. And if you want to protect yourself, the CDC says that you must do these three things with your mask now.
Read the original article at Better life.
In February, researchers at the University of Oxford found that tocilizumab, an anti-inflammatory drug frequently prescribed to individuals with rheumatoid arthritis, can reduce COVID mortality rates. When reviewing research from the Randomized Evaluation of COVID-19 Therapy (RECOVERY) study, the researchers found that COVID patients who received tocilizumab had a 29 percent death rate in the first 28 days of treatment versus a 33 death rate percent among patients who did not receive it prescribed the drug. And to get the latest guidance from COVID, Dr. Fauci says this is when you will have to wear a post-pandemic mask.
Rinsing your nose with a specific type of nasal spray may make you less susceptible to COVID, according to a new study. According to a preprint of an in vitro study published by bioRxiv, The Xclear Sinus Care nasal spray significantly reduced the amount of virus in a test sample. The researchers postulated that this was due to the combination of grapefruit seed extract (GSE) and xylitol, a non-caloric sweetener, used in the spray formula.
“GSE significantly reduces viral load, while xylitol prevents the virus from binding to the central protein in the cell wall,” explained the study authors. And if you are eager to protect yourself against COVID, if you live in those states, you can get a COVID vaccine at Rite Aid now.
Omega-3 fatty acids have emerged as an amazing way to reduce severe symptoms of COVID, according to a new study. According to the January 2021 survey published in medRxiv, individuals with the highest levels of omega-3 fatty acids in their blood had a 75% lower risk of death from COVID compared to those with lower levels of circulating omega-3. This “strongly suggests that these nutritionally available marine fatty acids may help reduce the risk of adverse outcomes in patients with COVID-19,” he explained. Arash Asher, MD, lead author of the study. And for the latest COVID news delivered straight to your inbox, sign up for our daily newsletter.
Melatonin, a popular sleeping aid, can help people avoid contracting COVID, says a recent study. A November 2020 study led by researchers at the Cleveland Clinic found that study participants who used melatonin were 30 percent less likely to develop COVID than those who did not use the supplement. However, this does not mean that you should go out and get yourself a bottle. “It is very important to note that these findings do not suggest that people should start taking melatonin without consulting their doctor,” said the study’s lead author. Feixiong Cheng, PhD, assistant staff at the Cleveland Clinic Institute of Genomic Medicine.